FDA Expands Use of RSV Vaccine to Include More Adults Arexvy now approved for people 50 years and older at increased risk of serious outcomes Jun 10, 2024
Lung Cancer Screening Rates Remain Low in the U.S., Especially in the South But one study showed that patient navigation added to usual care may increase uptake Jun 10, 2024
'Uncertainty' Is Indeed a Bad Word: A Second Opinion on Pandemic Communication Information should be presented to the public using a three-part approach Jun 09, 2024
Artery Inflammation and CV Events; Stepped Palliative Care for Lung Cancer Patients Also in TTHealthWatch: diets and medicine in IBS and active surveillance in prostate cancer Jun 08, 2024 podcast
Melatonin Use Tied to Decreased Risk of Age-Related Macular Degeneration Retrospective research isn't definitive but cheap supplement has been linked to better eye health Jun 07, 2024
Sleep Disturbance Common in Postmenopausal Women With Troublesome Hot Flashes Most reported trouble sleeping, staying asleep, and many said their sleep was of poor quality Jun 07, 2024
Juul Vaping Products' Stay of Execution Is Now More Official FDA rescinds marketing denials pending further review Jun 06, 2024
Paxlovid Trial Flops for COVID Pneumonia Small study found no decrease in mortality among inpatients in three countries Jun 06, 2024
Cucumbers Hospitalize 54; First H5N2 Bird Flu Death; FDA Warns on Oysters, Clams Health news and commentary gathered by Bվ staff Jun 06, 2024
Phrenic Nerve Stimulation Shows Benefits in Central Sleep Apnea With Heart Failure Use of the nerve stimulator tied to a fivefold higher chance of better clinical outcomes Jun 06, 2024
'Transformative': Novel Drug for Narcolepsy Effective in Mid-Stage Trial Unlike its predecessor, TAK-861 did not result in any hepatotoxicity or serious adverse events Jun 05, 2024
PPG-Based AI to Detect Obstructive Sleep Apnea Shows No Bias Based on Skin Color No significant differences between AI analysis and gold-standard polysomnography Jun 04, 2024
Insomnia Trajectory Tied to Subsequent Depression Risk Progressive worsening insomnia tied to greatest risk Jun 04, 2024
Limited-Stage SCLC Gets a New Standard of Care With Consolidation Durvalumab Median OS was 55.9 months in the durvalumab group compared with 33.4 months in the placebo group Jun 03, 2024
'Uncertainty' Isn't a Bad Word: U.S. Agencies Must Tighten Up H5N1 Communications More effective and efficient public messaging is the need of the hour Jun 03, 2024
'Practice Changing' Trial for Inoperable Locally Advanced NSCLC EGFR testing now needed for all patients with stage III disease, experts say Jun 02, 2024
Virtual and In-Person Palliative Care Equally Beneficial in Advanced Lung Cancer No differences observed in quality of life metric, patient and caregiver satisfaction Jun 02, 2024
Subcutaneous Amivantamab Plus Lazertinib Non-Inferior to IV Dosing in NSCLC Unexpectedly offers a possible overall survival benefit, researchers say Jun 01, 2024
Novel Bispecific in EGFR-Mutant Lung Cancer Boosts PFS After Targeted Agents China-based trial may present a hurdle to FDA approval, however Jun 01, 2024
Guillain-Barre Syndrome Rates After RSV Shots in Sync With Trial Data, CDC Says But compared with mRNA COVID-19 vaccines, GBS was more common than expected May 31, 2024
Unprecedented PFS Results in ALK-Positive Lung Cancer Trial "We have not seen anything close to this," says expert May 31, 2024
First U.S. Bird Flu Case With Respiratory Symptoms Emerges The third human case of H5N1 occurred in a Michigan dairy farm worker May 30, 2024
Smoking Isn't the Only Source of Nicotine Addiction in Town Emerging data suggest pharmacological interventions may help patients quit vaping May 29, 2024
Kids' Spirometry Results Differed When Switching to Race-Neutral Equations Magnitude of differences "substantially larger in children of Black race," researcher noted May 28, 2024
Not All COVID Patients Benefit From JAK Inhibitor Post-hoc analysis shows that body weight makes an important difference May 28, 2024
GLP-1 Agonists in Adolescents and Young Adults; Benefits of Cancer Drug Trials Also in TTHealthWatch: early diagnosis and treatment of COPD and asthma May 25, 2024 podcast
CDC Prepping for 'Possibility of Increased Risk to Human Health' From Bird Flu Approximately 350 recently exposed farm workers are being monitored May 24, 2024
BTK Inhibitor Likely to Get a Pass to Phase III in Uncontrolled Asthma Phase II trial misses main goal, but drugmaker set to forge ahead May 24, 2024
Inhaled Amikacin Shows Promise for Untreated MAC Lung Infections ARISE lays the ground work for registrational trial of Arikayce in earlier treatment setting May 23, 2024
Psychostimulant No Help in Relieving Cancer-Related Fatigue No significant differences in outcomes between methylphenidate, placebo May 22, 2024
New U.S. Human Case of Bird Flu Reported H5N1 in Michigan farmworker becomes second human case associated with outbreak in dairy cows May 22, 2024
Anti-Epilepsy Drug Improves Sleep Apnea Symptoms in Mid-Stage Trial AHI dipped by as much as 40% in patients who took sulthiame, but CPAP is still the gold standard May 22, 2024
Matthew Perry's Death Investigated; CDC H5N1 Surveillance; Trump Talks Birth Control Health news and commentary gathered by Bվ staff May 22, 2024
Tezepelumab Shows Potential for COPD, Negative Trial Notwithstanding Asthma drug may benefit patients with blood eosinophil counts indicative of type 2 inflammation May 22, 2024
Add-On Dupilumab for COPD Backed by Second Phase III Trial NOTUS study confirms fewer exacerbations with biologic for patients on maximum inhaled therapy May 21, 2024
Two Antibiotic Regimens Are Effective for M. Xenopi Pulmonary Infections Patients benefited from clarithromycin or moxifloxacin plus rifampin/ethambutol May 21, 2024
Beta-Blocker Fails to Prevent COPD Exacerbations However, trial results don't affirm safety risks suggested by other studies May 20, 2024
Finding Undiagnosed Asthma, COPD and Treating It Shows Benefit in Trial Healthcare utilization for respiratory illness halved while quality of life, symptoms improved May 20, 2024
Once-Promising Drug for Idiopathic Pulmonary Fibrosis Fails in Phase III Trial An open-label extension trial of pamrevlumab was cancelled due to these results May 20, 2024